TP53 and neoplasm: S-K-NAS p53MUT orthotopic xenografts also had decreased tumor weights when treated with 100 mg/kg of pevonedistat compared to the vehicle control (p = 0.003), indicating that pevonedistat is highly effective at decreasing tumor weight in preclinical models of neuroblastoma, independent of p53 status.